Search research articles
Contact Us
Filters
Showing results (381-390 of 1,126) with videos related to
Page
of 113
Sort By:
World Journal of Urology
|
April 10, 2015
Patterns of use and patient characteristics: brachytherapy for localized prostate cancer in octo- and nonagenarians
Roger Valdivieso, Katharina Boehm, Malek Meskawi, et al.
Cancer Research
|
January 28, 2012
PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer
Laurent Lessard, David P Labbé, Geneviève Deblois, et al.
The Journal of Urology
|
April 7, 2020
Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities
Marina Deuker, Franziska Stolzenbach, Giuseppe Rosiello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2005
Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid
Robert E Coleman, Pierre Major, Allan Lipton, et al.
Anticancer Research
|
August 2, 2019
Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis
Carlotta Palumbo, Angela Pecoraro, Sophie Knipper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide
Andrew J Armstrong, Arun A Azad, Taro Iguchi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
March 16, 2016
Medical management of benign prostatic hyperplasia: Results from a population-based study
Mohamed Bishr, Katharina Boehm, Vincent Trudeau, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 25, 2016
Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone
Fred Saad, Eric Winquist, Stacey Hubay, et al.
The Canadian Journal of Urology
|
May 10, 2005
Validation of 1997 Partin Tables' lymph node invasion predictions in men treated with radical prostatectomy in Montreal Quebec
Pierre I Karakiewicz, Jean-Baptiste Lattouf, Paul Perrotte, et al.
BJU International
|
April 4, 2008
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy
Jochen Walz, Nazareno Suardi, Shahrokh F Shariat, et al.
Page
of 113
Search research articles
Search
Showing results (381-390 of 1,126) with videos related to
Sort By:
Page
of 113
World Journal of Urology
|
April 10, 2015
Patterns of use and patient characteristics: brachytherapy for localized prostate cancer in octo- and nonagenarians
Roger Valdivieso, Katharina Boehm, Malek Meskawi, et al.
Cancer Research
|
January 28, 2012
PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer
Laurent Lessard, David P Labbé, Geneviève Deblois, et al.
The Journal of Urology
|
April 7, 2020
Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities
Marina Deuker, Franziska Stolzenbach, Giuseppe Rosiello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2005
Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid
Robert E Coleman, Pierre Major, Allan Lipton, et al.
Anticancer Research
|
August 2, 2019
Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis
Carlotta Palumbo, Angela Pecoraro, Sophie Knipper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2026
Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide
Andrew J Armstrong, Arun A Azad, Taro Iguchi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
March 16, 2016
Medical management of benign prostatic hyperplasia: Results from a population-based study
Mohamed Bishr, Katharina Boehm, Vincent Trudeau, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 25, 2016
Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone
Fred Saad, Eric Winquist, Stacey Hubay, et al.
The Canadian Journal of Urology
|
May 10, 2005
Validation of 1997 Partin Tables' lymph node invasion predictions in men treated with radical prostatectomy in Montreal Quebec
Pierre I Karakiewicz, Jean-Baptiste Lattouf, Paul Perrotte, et al.
BJU International
|
April 4, 2008
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy
Jochen Walz, Nazareno Suardi, Shahrokh F Shariat, et al.
Page
of 113